Literature DB >> 26603935

Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.

Xiang Zhu1, Yuan-Bo Wu2, Jian Zhou3, Dong-Mei Kang4.   

Abstract

BACKGROUND: Hepatic insulin resistance is a major characteristic of type 2 diabetes mellitus. LncRNA MEG3 has been shown to correlate to hepatic glucose production; however, the underlying mechanism remains unclear. This study aims to investigate the role of MEG3 in hepatic insulin resistance.
METHODS: High-fat diet mice, ob/ob mice and mice primary hepatocytes were used in this study. Expression of MEG3, FoxO1, G6pc and Pepck were determined by real-time PCR. FoxO1, G6pc, Pepck, HDAC1 and HDAC3 protein levels were analyzed by western blotting. Hepatic gluconeogenesis, glycogen accumulation, triglyceride and glycogen contents were measured by corresponding assay or kit, and body weight was monitored after an overnight fast.
RESULTS: Gene expression of MEG3 was upregulated in high-fat diet and ob/ob mice and increased by palmitate, oleate or linoleate. MEG3 overexpression significantly increased FoxO1, G6pc, Pepck mRNA expressions and hepatic gluconeogenesis and suppressed insulin-stimulated glycogen synthesis in primary hepatocytes, whereas palmitate-induced increase of FoxO1, G6pc and Pepck protein expressions could be reversed by MEG3 interference. In addition, high fat enhanced expression of lncRNA MEG3 in hepatocytes through histone acetylation. Furthermore, MEG3 interference could reverse the up-regulation of triglyceride as well as impaired glucose tolerance and down-regulation of glucogen content in high-fat diet mice or ob/ob mice.
CONCLUSION: Upregulation of lncRNA MEG3 enhances hepatic insulin resistance via increasing foxO1expression, suggesting that MEG3 may be a potential target and therapeutic strategy for diabetes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FoxO1; Hepatic insulin resistance; Primary hepatocytes; lncRNA MEG3

Mesh:

Substances:

Year:  2015        PMID: 26603935     DOI: 10.1016/j.bbrc.2015.11.048

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  51 in total

Review 1.  Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.

Authors:  Linda Sommese; Alberto Zullo; Francesco Paolo Mancini; Rossella Fabbricini; Andrea Soricelli; Claudio Napoli
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

2.  The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice.

Authors:  Xianwei Cui; Jingmin Tan; Yujie Shi; Chen Sun; Yun Li; Chenbo Ji; Jun Wu; Zhao Zhang; Siyu Chen; Xirong Guo; Chang Liu
Journal:  J Biol Chem       Date:  2018-01-23       Impact factor: 5.157

3.  Long Non-coding RNA in Liver Metabolism and Disease: Current Status.

Authors:  Yulan Zhao; Jianguo Wu; Suthat Liangpunsakul; Li Wang
Journal:  Liver Res       Date:  2017-12-02

Review 4.  Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus.

Authors:  Weiyue Zhang; Juan Zheng; Xiang Hu; Lulu Chen
Journal:  Endocrine       Date:  2019-07-25       Impact factor: 3.633

5.  Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.

Authors:  Li Zhang; Zhihong Yang; Jocelyn Trottier; Olivier Barbier; Li Wang
Journal:  Hepatology       Date:  2016-12-24       Impact factor: 17.425

Review 6.  Long Non-Coding RNAs: A Novel Paradigm for Toxicology.

Authors:  Joseph L Dempsey; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2016-11-17       Impact factor: 4.849

Review 7.  Maternally expressed gene 3 in metabolic programming.

Authors:  Samuel Hamilton; Rafael de Cabo; Michel Bernier
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-01       Impact factor: 4.490

Review 8.  Long non-coding RNA-mediated regulation of glucose homeostasis and diabetes.

Authors:  Xinghui Sun; Danny Wong
Journal:  Am J Cardiovasc Dis       Date:  2016-05-18

Review 9.  Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs.

Authors:  Neha Goyal; Devesh Kesharwani; Malabika Datta
Journal:  Cell Mol Life Sci       Date:  2018-01-31       Impact factor: 9.261

Review 10.  Epigenetics of metabolic syndrome.

Authors:  Caryn Carson; Heather A Lawson
Journal:  Physiol Genomics       Date:  2018-09-21       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.